[
  {
    "ts": null,
    "headline": "Why Is Moderna, Inc. (MRNA) Among the Worst Performing Healthcare Stocks in 2024?",
    "summary": "We recently compiled a list of the 10 Worst Performing Healthcare Stocks in 2024. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other healthcare stocks. The Evolving Landscape of Global Healthcare Spending and Innovation The healthcare industry remains a vital and resilient sector which is driven […]",
    "url": "https://finnhub.io/api/news?id=d49f47bef48f8ec4d1b365d1175eb690b37e3c510a45c40d7d18ed3517359aa6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732717870,
      "headline": "Why Is Moderna, Inc. (MRNA) Among the Worst Performing Healthcare Stocks in 2024?",
      "id": 131670059,
      "image": "https://s.yimg.com/ny/api/res/1.2/ss7LBw0NkRteO60GW_xAKA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/3355ab936103e2e5a7e230b963727612",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 10 Worst Performing Healthcare Stocks in 2024. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other healthcare stocks. The Evolving Landscape of Global Healthcare Spending and Innovation The healthcare industry remains a vital and resilient sector which is driven […]",
      "url": "https://finnhub.io/api/news?id=d49f47bef48f8ec4d1b365d1175eb690b37e3c510a45c40d7d18ed3517359aa6"
    }
  },
  {
    "ts": null,
    "headline": "Moderna price target lowered to $45 from $59 at JPMorgan",
    "summary": "JPMorgan lowered the firm’s price target on Moderna (MRNA) to $45 from $59 and keeps an Underweight rating on the shares. The firm updated estimates for the company and refreshed its script trend analysis for the COVID vaccines. While the start of the U.S. vaccination season was pulled forward compared to 2023, the overall the peak is lower based on COVID vaccine trends up to mid-November, the analyst tells investors in a research note. Published first on TheFly – the ultimate source for real-ti",
    "url": "https://finnhub.io/api/news?id=462f68bf4f82f1dce787122e637ed03bc2618cc2988df6ed615a027cb55493eb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732708862,
      "headline": "Moderna price target lowered to $45 from $59 at JPMorgan",
      "id": 131666313,
      "image": "",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "JPMorgan lowered the firm’s price target on Moderna (MRNA) to $45 from $59 and keeps an Underweight rating on the shares. The firm updated estimates for the company and refreshed its script trend analysis for the COVID vaccines. While the start of the U.S. vaccination season was pulled forward compared to 2023, the overall the peak is lower based on COVID vaccine trends up to mid-November, the analyst tells investors in a research note. Published first on TheFly – the ultimate source for real-ti",
      "url": "https://finnhub.io/api/news?id=462f68bf4f82f1dce787122e637ed03bc2618cc2988df6ed615a027cb55493eb"
    }
  },
  {
    "ts": null,
    "headline": "Invesco Equally-Weighted S&P 500 Fund Q3 2024 Commentary",
    "summary": "The fundâs positioning within the information technology and industrial sectors had the largest positive effect on relative return.",
    "url": "https://finnhub.io/api/news?id=1eaa728bac120999a9735daa287e77798dbdb8e9fdb2564b66fdc87f2c394ac8",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732686300,
      "headline": "Invesco Equally-Weighted S&P 500 Fund Q3 2024 Commentary",
      "id": 131663340,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1936201908/image_1936201908.jpg?io=getty-c-w1536",
      "related": "MRNA",
      "source": "SeekingAlpha",
      "summary": "The fundâs positioning within the information technology and industrial sectors had the largest positive effect on relative return.",
      "url": "https://finnhub.io/api/news?id=1eaa728bac120999a9735daa287e77798dbdb8e9fdb2564b66fdc87f2c394ac8"
    }
  }
]